Deep Dive
来自我们记者的行业洞察
Antitrust agencies rely on consumer reports of anticompetitive behavior, experts question their reliability
U.S. antitrust agencies launched a new portal to encourage public reporting of anticompetitive practices in healthcare. Experts say this may generate investigative leads but worry that consumers may struggle to accurately identify anticompetitive behavior, and agencies could face a flood of complaints and resource constraints.
California and Oregon Advance Universal Healthcare: Federal Support Becomes Key Variable
California and Oregon passed legislation last year setting timelines for developing universal healthcare systems. Supporters say it could save billions of dollars and improve access to care, while opponents worry it could disrupt the existing healthcare system. Both states' plans require federal waivers, but experts believe that amid the federal political stalemate, success depends on the White House's political will.
Steward Health Faces Bankruptcy Risk, Few Options Remain Under Massive Debt
Steward Health Care Group is facing a severe financial crisis and could become one of the largest hospital bankruptcies in decades. The company must prove to lenders by the end of the month that it can repay its debts, or it may enter bankruptcy proceedings. Analysts note that its debt burden is massive, and its self-rescue plan faces multiple challenges, including regulatory hurdles and a credit crunch.
Change Healthcare cyberattack sounds alarm for cybersecurity in the healthcare industry
The Change Healthcare cyberattack has continued to impact the healthcare industry for over a month, prompting deep reflection on cybersecurity and business continuity. Experts urge healthcare organizations to conduct risk analyses, establish vendor redundancies, and pay attention to the federal government's upcoming cybersecurity incentives and penalties.
Cigna Caps Annual Cost Increases for High-Priced GLP-1 Weight-Loss Drugs
Cigna announced that through agreements between its pharmacy benefit manager Express Scripts and drug manufacturers, it will cap annual spending increases for GLP-1 drugs at no more than 15% for employers and health plans participating in the Evernorth weight management program, in response to rising obesity medication costs.
Health insurers brace for continued high Medicare Advantage medical costs
Medicare Advantage medical costs dominated the fourth-quarter earnings season, with insurers diverging in their forecasts for 2024 cost trends. UnitedHealth, Centene, Elevance, and Cigna maintained or raised expectations, while Humana and CVS lowered earnings guidance due to rising healthcare utilization. The industry generally plans to cut benefits or raise premiums to protect margins, while facing challenges from government payment rate adjustments and regulatory changes.
2024 Health Insurance Industry Trends Outlook
In 2024, the health insurance industry begins amid cost pressures, regulatory uncertainty, and election-year political factors. Experts predict: the uninsured rate will rise, employers will increase investment in mental health, GLP-1 drug coverage will grow slowly, Medicare Advantage will continue to expand but face regulatory scrutiny, PBMs will introduce transparency options, and merger and acquisition activity will continue.
Key Trends to Watch for Hospitals and Healthcare Providers in 2024
In 2024, U.S. hospitals and healthcare providers will continue to face pressure from thin operating margins, with credit rating agencies forecasting a negative-to-stable industry outlook despite executives' efforts to control costs. This article reviews three key trends: increased investment in outpatient care and divestiture of expensive service lines, insourcing staff in critical areas while outsourcing non-core functions, and continued consolidation despite regulatory and physician opposition.
2024 Medical Technology Trends Outlook: AI Integration, M&A Recovery, and Upgraded Cybersecurity Regulation
After the digital health investment boom driven by the COVID-19 pandemic subsides, the medical technology industry is expected to usher in a period of consolidation and evolution in 2024. Alex Lennox-Miller, an analyst at market intelligence firm CB Insights, noted that changes this year may reflect more of an evolution of existing technologies rather than disruptive innovation. Investment in digital health will normalize, and M&A activity is expected to rebound; following the 2023 hype around generative AI, the industry's focus is shifting toward infrastructure building and transparency; meanwhile, regulators are preparing stricter cybersecurity standards to address increasingly frequent data breaches.